Spectral AI, Inc.

NASDAQ:MDAI

Medical - Devices

Healthcare
$1.57 +0.28%

+$0.01 today

Market cap
$50.53M
Beta
1.15
P/E (TTM)
-4.0
EPS (TTM)
-$0.45
52W Low $1.18High $3.21

Volume 0.07M

Average 1.00M

MDAI Operating Cash Flow

Cash generated by the company's core business operations during the period.

Spectral AI, Inc.NASDAQ: MDAI

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow growth accelerates

Q1 FY2026 operating cash flow of $3.73M (cash outflow) rose 147.7% year over year, ahead of the +51.3% change in trailing-twelve-month operating cash flow. Sequentially, it rose 46.1% from the prior quarter. Over 3 fiscal years it compounded at +104.4% a year.

Context

  • Operating cash flow amounted to 50.5% of revenue in FY2025, up 19.4 pp from a year earlier.
  • Operating cash flow grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +147.7% holds above the trailing-twelve-month pace of +51.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$3.73M+46.1% QoQ
Last fiscal yearDec 2025
-$9.92M+7.8% YoY
LTMMar 2026
-$12.14M+51.3% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+147.7%——
1 year+7.8%——
3-year CAGR+104.4%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(9.92M) USD
Year-over-year change
-7.8%

Operating Cash Flow vs competitors

How MDAI compares with its peers on the latest reported figures

  • MDAI's LTM Mar 2026 operating cash flow of $12.14M is the 5th largest of the 9 companies compared; the peer median is $13.44M.
  • Its year-over-year change of +51.3% is the highest of 9, against a peer median of -13.1%.
  • Operating cash flow amounts to 72.7% of revenue for MDAI, versus a peer median of 39.0%.
MDAI Competitors Peer median
Operating Cash Flow for MDAI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IPSCCentury Therapeutics, Inc.LTM Mar 2026$94.5M -17.5%——
KPTIKaryopharm Therapeutics Inc.LTM Mar 2026$59.11M -51.8%-20.4%39.1%
TELATELA Bio, Inc.LTM Jun 2026$31.14M -8.8%-11.5%39.0%
EQEquillium, Inc.LTM Mar 2026$18.88M +2.6%+37.6%—
MDAISpectral AI, Inc.LTM Mar 2026$12.14M +51.3%+104.4%72.7%
COEPCoeptis Therapeutics, Inc.LTM Mar 2026$8M +12.4%+30.4%565.5%
ECORelectroCore, Inc.LTM Mar 2026$6.84M -21.8%-21.1%19.6%
TELOTelomir Pharmaceuticals, Inc. Common StockLTM Mar 2026$4.6M +15.1%+98.9%—
SRTSSensus Healthcare, Inc.LTM Mar 2026$548K -111.7%—2.4%
Peer median (excluding MDAI) $13.44M-13.1%+9.5%39.0%

Competitors are the stored peer set for MDAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(3.99M)(2.91M)(20.85M)(15.32M)(7.57M)
Depreciation & Amortization1K568K722K588K635K
Deferred Income Tax00000
Stock-Based Compensation1.37M1.16M1.24M1.03M1.12M
Change in Working Capital2K84K1.63M(1.87M)(2.03M)
Accounts Receivables1.19M(1.41M)566K(159K)1.24M
Inventory00(230K)(195K)(413K)
Accounts Payables(2.4M)1.35M(935K)1.43M(1.03M)
Other Working Capital1.22M145K2.23M(2.94M)(1.83M)
Other Non-Cash Items(298K)(57K)4.02M6.37M(2.07M)
Operating Cash Flow(2.92M)(1.16M)(13.24M)(9.2M)(9.92M)
Capital Expenditures(7K)0000
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(7K)0000
Debt Repayment(701K)(785K)(483K)5.34M6.71M
Common Stock Issued14.62M03.35M4.06M13.41M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities4K0976K177K0
Financing Cash Flow13.92M(785K)3.84M9.58M20.12M
Effect of Forex Changes015.35M12K(9K)37K
Net Change in Cash11M(1.95M)(9.38M)367K10.24M
Free Cash Flow(2.93M)(1.16M)(13.24M)(9.2M)(9.92M)

Spectral AI, Inc.

NASDAQ:MDAI

Intrinsic Alpha fair value

Locked

Current Price

$1.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.